Strategic Early Development Asset Lead

Ipsen Biopharm Ltd in the United Kingdom is seeking an Early Development Asset Lead (EDAL) to drive scientific and program leadership for one or more early-stage assets. You will lead the Early Development Asset Team (EDT) spanning clinical, regulatory, CMC and translational activities, ensuring rigorous strategy and accountable portfolio decisions.

The EDAL will align with Therapeutic Area strategy, championing assigned programs, articulating goals and scientific rationale, and representing the